- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
14 result(s) found for: TIPS.
Displaying page 1 of 1.
EudraCT Number: 2018-004323-37 | Sponsor Protocol Number: PEARL-trial | Start Date*: 2019-06-06 | ||||||||||||||||||||||||||
Sponsor Name:Academic Medical Centre | ||||||||||||||||||||||||||||
Full Title: Prevention of hepatic Encephalopathy by Administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt: a multi-c... | ||||||||||||||||||||||||||||
Medical condition: post-TIPS Hepatic Encephalopathy (HE) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) BE (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000931-20 | Sponsor Protocol Number: TIPS-EE | Start Date*: 2012-05-25 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: EFFECT OF ALBUMIN INFUSION TO PREVENT OVERT HEPATIC ENCEPHALOPATHY AFTER TRANSGIUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS). | |||||||||||||
Medical condition: PREVENTION OF HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS WHO UNDERGO TIPS PLACEMENT | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001132-19 | Sponsor Protocol Number: 1-10-72-67-17 | Start Date*: 2017-07-04 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: Effects of Metformin on portal hypertension in patients with cirrhosis. | ||||||||||||||||||
Medical condition: cirrhosis and portal hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021499-27 | Sponsor Protocol Number: Kreussler-Dynexan® Mundgel-0410 | Start Date*: 2010-09-13 | |||||||||||
Sponsor Name:Chemische Fabrik Kreussler & Co. GmbH | |||||||||||||
Full Title: A Prospective, Randomized, Multi-centre, Placebo-controlled, Double blind, Comparative Study To Evaluate the Efficacy and Safety of Dynexan® Mundgel in Subjects with Acute Teething Pain | |||||||||||||
Medical condition: Teething in babies which can lead to symptoms like irritability, rash, and severe pain. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014721-16 | Sponsor Protocol Number: IRRB/19/09 | Start Date*: 2009-11-18 |
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE | ||
Full Title: Controlled randomized pilot study for characterization and identification of CD34+ stem cells in the splancnic distrect after GCSF stimolation in cirrhotic patients | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-004220-13 | Sponsor Protocol Number: Q-301 | Start Date*: 2005-06-08 | |||||||||||
Sponsor Name:Q-Develop AB/co Freddie Norberg | |||||||||||||
Full Title: Treatment of vulvar vestibulitis by an antioxidant cream: a double-blind, placebo-controlled, parallel group multi-center study | |||||||||||||
Medical condition: Vulvar vestibulitis, a recently discovered disease, which mainly affects young women. The symptoms are severe vaginal pain. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005523-27 | Sponsor Protocol Number: CIRROXABAN | Start Date*: 2015-07-30 |
Sponsor Name:INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS) | ||
Full Title: Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002476-24 | Sponsor Protocol Number: EP-DICLO-TIO/F-01-2015 | Start Date*: 2015-10-13 | |||||||||||
Sponsor Name:Epifarma S.r.l. | |||||||||||||
Full Title: Randomized, double-blind, parallel-groups, active-controlled trial to evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injection, in improvin... | |||||||||||||
Medical condition: low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005412-10 | Sponsor Protocol Number: OCR002-HE209 | Start Date*: 2014-08-25 | |||||||||||
Sponsor Name:Ocera Therapeutics Inc | |||||||||||||
Full Title: Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemi... | |||||||||||||
Medical condition: Hepatic encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) CZ (Completed) AT (Completed) HU (Completed) IT (Completed) DE (Completed) NL (Completed) BE (Completed) DK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-005008-16 | Sponsor Protocol Number: STOPPIT-01 | Start Date*: 2021-03-08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a double-blind, placebo-controlled trial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Liver cirrhosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002226-36 | Sponsor Protocol Number: N-003-CRD002 | Start Date*: 2016-11-04 | ||||||||||||||||
Sponsor Name:Noorik Biopharmaceuticals AG | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled, escalating-dose study of the effect of N-003 on renal function, pharmacodynamics, pharmacokinetics, safety and tolerability in patients with advanced liver disease. | ||||||||||||||||||
Medical condition: Decompensated cirrhosis of the liver | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GR (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016500-24 | Sponsor Protocol Number: BLEPS | Start Date*: 2010-05-11 | |||||||||||||||||||||
Sponsor Name:Fundació Clinic per a la Recerca Biomèdica | |||||||||||||||||||||||
Full Title: Estudio multicéntrico, aleatorizado, doble-ciego, controlado con placebo, sobre la eficacia de la asociación de simvastatina al tratamiento estándar en la prevención de la recidiva hemorrágica en p... | |||||||||||||||||||||||
Medical condition: Prevención de la recidiva hemorrágica en pacientes con cirrosis y hemorragia por varices esofágicas. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-000724-37 | Sponsor Protocol Number: EP-DIC-TIO/75+4-F-01-2022 | Start Date*: 2022-11-08 | ||||||||||||||||
Sponsor Name:EPIFARMA S.R.L. | ||||||||||||||||||
Full Title: Randomized, double-blind, parallel-groups, active - and placebo-controlled study to Evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injectio... | ||||||||||||||||||
Medical condition: Low back pain (LBP) is one of the most frequent and disabling health problems. It is estimated that about 80% of adults will experience an episode of acute or chronic LBP at least once during their... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Trial now transitioned) GR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002404-18 | Sponsor Protocol Number: NRL972-03/2006 (CIR) | Start Date*: 2008-04-04 | |||||||||||
Sponsor Name:Norgine Limited | |||||||||||||
Full Title: A multi-centre, multi-national open study in patients with hepatic cirrhosis to characterise the association between the pharmacokinetics of NRL972 and disease severity | |||||||||||||
Medical condition: Hepatic cirrhosis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) IT (Completed) BG (Completed) AT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
